CORREVIO PHARMA CORP's ticker is and the CUSIP is 22026V955. A total of 3 filers reported holding CORREVIO PHARMA CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,000 | -97.4% | 7,600 | -85.6% | 0.00% | -100.0% |
| Q2 2019 | $114,000 | +58.3% | 52,800 | +130.6% | 0.00% | 0.0% |
| Q1 2019 | $72,000 | -28.0% | 22,900 | -42.8% | 0.00% | 0.0% |
| Q4 2018 | $100,000 | +900.0% | 40,000 | +1500.0% | 0.00% | – |
| Q3 2018 | $10,000 | -9.1% | 2,500 | -16.7% | 0.00% | – |
| Q2 2018 | $11,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 52,800 | $114,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 23 | $4,000 | 0.00% |